[Tianjin, China - May 2025] "The NAHlEM Chinese Orthopedic Society 2025 Annual Meeting & The 2nd Orthopedic Academic Conference" was successfully held in Tianjin from May 23 to 25, 2025. Hosted by the The NAHlEM Chinese Orthopedic Society(here in after referred to as the Orthopedic Society), the conference gathered leading orthopedic experts, scholars, and industry representatives from across the country to explore the latest advancements and future directions in orthopedic medicine. 

Under the theme "Innovation Leads the Future of Orthopedics," the conference aimed to implement the ‘Healthy China’ strategy, elevate clinical standards in Orthopedics, and promote high-quality development in the field. Experts engaged in in-depth discussions on technological innovation, clinical practice, and discipline development, sharing cutting-edge research and practical experiences. 

orthopedic

Leihu Medical Actively Responds, Building an Innovative Orthopedic Ecosystem

At the conference, Leihu Medical was honored to become a member unit of the Orthopedic Society. Moving forward, Leihu Medical will actively respond to the conference’s call, adhering to the principle of "Innovation Drives a Healthy Future." Together with industry peers, the company commits to: 

- Driving technological advancement through innovation

- Promoting healthcare equity with responsibility

- Enhancing international cooperation with openness

- Strengthening disciplinary foundations through talent development

By fostering a collaborative and innovative Orthopedic ecosystem, Leihu Medical aims to inject strong momentum into the ‘Healthy China’ strategy. 

The company showcased its innovative external fixation product series at the conference. A Leihu Medical R&D representative stated: "We are honored to participate in this prestigious academic event. Leihu will continue to increase R&D investment and actively engage in the Orthopedic Branch’s academic activities, including training programs, seminars, and salons, to contribute to the professional development of the Orthopedic community." 

Flagship Products: Precision Shaping, Revolutionizing External Fixation Technology

Leihu Medical presented a comprehensive product line covering ‘distal limb fractures, postoperative rehabilitation, and sports medicine’, designed with ‘precision, efficiency, and patient-centricity’ in mind. Key innovations included: 

Hand & Foot Medical External Fixation Braces

1. Advanced biomechanical design - with lightweight composite materials ensures superior stability and comfort. 

2. Breathable, ergonomic materials - reduce skin irritation and significantly improve patient compliance. 

3. Modular customization - meets individualized treatment needs while simplifying clinical procedures. 

These products have been successfully applied in top-tier hospitals such as Henan Provincial People’s Hospital, receiving high praise from physicians for their safety, efficacy, and innovation. An attending Orthopedic director remarked: "These innovative products provide new clinical options that enhance treatment outcomes while improving patient experience."

Looking Ahead: Deepening Collaboration for High-Quality Orthopedic Development

The conference chair emphasized in the closing ceremony: "The prevention and treatment of Orthopedic diseases require persistent efforts from academia, industry, and healthcare professionals. This conference will undoubtedly foster further collaboration and innovation, injecting new vitality into the advancement of Orthopedics." 

Leihu Medical’s General Manager stated: "Orthopedic medicine plays a crucial role in the Healthy China strategy. We will continue to focus on Orthopedic innovation, explore high-quality development pathways, and work with industry partners to build a new era of Orthopedic progress, contributing to the 'Healthy China 2030' vision." 

In the future, Leihu Medical will remain committed to addressing clinical needs, intensifying R&D efforts, and promoting the advancement of Orthopedic technologies through academic exchanges and clinical research collaborations, ultimately benefiting more patients worldwide.